Deutsche Bank’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-70,524
| Closed | -$76K | – | 4097 |
|
2021
Q4 | $76K | Sell |
70,524
-579
| -0.8% | -$624 | ﹤0.01% | 3731 |
|
2021
Q3 | $210K | Buy |
71,103
+18,149
| +34% | +$53.6K | ﹤0.01% | 3518 |
|
2021
Q2 | $159K | Sell |
52,954
-7,795
| -13% | -$23.4K | ﹤0.01% | 3864 |
|
2021
Q1 | $198K | Buy |
60,749
+41,287
| +212% | +$135K | ﹤0.01% | 3603 |
|
2020
Q4 | $80K | Buy |
19,462
+13,394
| +221% | +$55.1K | ﹤0.01% | 3887 |
|
2020
Q3 | $33K | Buy |
6,068
+547
| +10% | +$2.98K | ﹤0.01% | 3958 |
|
2020
Q2 | $37K | Buy |
5,521
+3,023
| +121% | +$20.3K | ﹤0.01% | 3874 |
|
2020
Q1 | $8K | Sell |
2,498
-5,929
| -70% | -$19K | ﹤0.01% | 3954 |
|
2019
Q4 | $58K | Buy |
8,427
+6,323
| +301% | +$43.5K | ﹤0.01% | 3799 |
|
2019
Q3 | $7K | Sell |
2,104
-6,669
| -76% | -$22.2K | ﹤0.01% | 4351 |
|
2019
Q2 | $31K | Sell |
8,773
-3,976
| -31% | -$14K | ﹤0.01% | 4419 |
|
2019
Q1 | $44K | Sell |
12,749
-1,772
| -12% | -$6.12K | ﹤0.01% | 4376 |
|
2018
Q4 | $111K | Buy |
+14,521
| New | +$111K | ﹤0.01% | 4032 |
|